✓an inhibitor of GSK3α/β (IC50 = ~78 nM) [306]✓reduces p-RPS6 through inactivating S6K1 in breast cancer cells, colon cancer, kidney cells, osteosarcoma cells, and prostate cancer cells [83]. Here, GSK3A is linked to malignant colon neoplasm.